InflaRx logo

InflaRx

IFRX | NASDAQ
Chart Builder DCF Calculator
$1.18
+$0.01 (+0.85%)
At close: Nov 16, 2026, 4:00 PM ET
$1.18
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
+0.85%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
51
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #256/1021 (Top 25%)

Key Statistics

Market Data

Market Cap $173.89M
1D Range
1.16 1.20
52W Range
0.83 2.74

Valuation (TTM)

PE -3.08
PB 1.07
EV/EBITDA -1.38

Valuation (NTM)

Forward PE N/A
Forward PEG 0.05
Price Target $5.50
Loading financial charts...

Profile

InflaRx N.V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel inhibitors leveraging C5a technology, primarily operating in Germany and the United States. The co...

Sector Healthcare
Industry Biotechnology
Employees 65
IPO Date Nov 7, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$5.50
Upside
+366.10%
Buy (4)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.